AstraZeneca
More News
-
AstraZeneca's Tagrisso plus chemo approved by China for first-line cancer therapy
AstraZeneca says approval by China's NMPA based on trials on patients given combination treatment
-
AstraZeneca, AI biologics firm Absci tie up on cancer drug
AstraZeneca signs deal worth $247 million with AI biologists Absci to design new antibody to fight cancer
-
AstraZeneca China summoned over suspected fraud
The company says some employees had altered or participated in altering patients' testing reports
-
Second batch of AstraZeneca vaccine arrives in Islamabad
The second batch of more than 1.2 million jabs reached Islamabad today
-
Britain hosts G-7 health summit amid pressure to broaden Covid vaccine access
British foreign minister says equitable access to vaccines will be at the top of agenda when G7 leaders meet
-
Covid fight could return ‘to square one’: experts sound vaccines alarm
COVAX, which is critical for poorer countries, relies on AstraZeneca shots made by the Serum Institute of India
-
Current Covid vaccines appear protective against variants, WHO Europe says
Official urges authorities in region where Covid was caused by Indian variant to remain vigilant
-
Bangladesh urges India for immediate release of purchased vaccines
New Delhi assures Dhaka it would help get US vaccines on priority basis, says minister
-
India reports 26 'suspected' cases of bleeding, clotting after AstraZeneca vaccine
This is the first time India reported any serious reaction to use of vaccine
-
AstraZeneca not for women under 40: Health Ministry
New guidelines restrict the use of Oxford-AstraZeneca vaccine for women under the age of 40
1719396069-0/BeFunky-collage-(30)1719396069-0-405x300.webp "astrazeneca s tagrisso plus chemo approved by china for first line cancer therapy")
